308 related articles for article (PubMed ID: 10047434)
1. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
Genth E; Mierau R
Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
[TBL] [Abstract][Full Text] [Related]
4. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
5. [Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies].
Zheng YM; Hao HJ; Liu YL; Guo J; Zhao YW; Zhang W; Yuan Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1088-1092. PubMed ID: 33331318
[TBL] [Abstract][Full Text] [Related]
6. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
8. Humoral immunity in polymyositis/dermatomyositis.
Targoff IN
J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
[TBL] [Abstract][Full Text] [Related]
9. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
10. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.
Yamasaki Y; Satoh M; Mizushima M; Okazaki T; Nagafuchi H; Ooka S; Shibata T; Nakano H; Ogawa H; Azuma K; Maeda A; Tonooka K; Ito H; Takakuwa Y; Inoue M; Mitomi H; Kiyokawa T; Tsuchida K; Matsushita H; Mikage H; Murakami Y; Chan JY; Ozaki S; Yamada H
Mod Rheumatol; 2016; 26(3):403-9. PubMed ID: 26344678
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
Mahler M; Miller FW; Fritzler MJ
Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody profiles in the sera of European patients with myositis.
Brouwer R; Hengstman GJ; Vree Egberts W; Ehrfeld H; Bozic B; Ghirardello A; Grøndal G; Hietarinta M; Isenberg D; Kalden JR; Lundberg I; Moutsopoulos H; Roux-Lombard P; Vencovsky J; Wikman A; Seelig HP; van Engelen BG; van Venrooij WJ
Ann Rheum Dis; 2001 Feb; 60(2):116-23. PubMed ID: 11156543
[TBL] [Abstract][Full Text] [Related]
14. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
[TBL] [Abstract][Full Text] [Related]
15. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.
Sánchez-Montalvá A; Fernández-Luque A; Simeón CP; Fonollosa-Plà V; Marín A; Guillén A; Vilardell M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-177-82. PubMed ID: 25372801
[TBL] [Abstract][Full Text] [Related]
16. Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
Arase N; Tsuji H; Takamatsu H; Jin H; Konaka H; Hamaguchi Y; Tonomura K; Kotobuki Y; Ueda-Hayakawa I; Matsuoka S; Hirano T; Yorifuji H; Murota H; Ohmura K; Nakashima R; Sato T; Kumanogoh A; Katayama I; Arase H; Fujimoto M
J Autoimmun; 2022 Jan; 126():102774. PubMed ID: 34896887
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
[TBL] [Abstract][Full Text] [Related]
18. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
Infantino M; Manfredi M; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Bizzaro N
Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease.
Hirakata M; Mimori T; Akizuki M; Craft J; Hardin JA; Homma M
Arthritis Rheum; 1992 Apr; 35(4):449-56. PubMed ID: 1567494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]